New standards of care for treatment of diffuse large B-cell lymphoma.

Abeyakoon, Chathuri; Gregory, Gareth P

Abeyakoon, Chathuri; Gregory, Gareth P.

Abeyakoon C; Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Gregory GP; Monash Haematology, Monash Health, Clayton, Victoria, Australia.

Br J Haematol ; 204(4): 1132-1134, 2024 Apr.

Article en En | MEDLINE | ID: mdl-38251726

ABSTRACT

ABSTRACT

Treatment of newly diagnosed diffuse large B-cell lymphoma with rituximab and CHOP (R-CHOP) has been largely unchanged for the last two decades. The Guideline by Fox et al. provides new evidence-based therapeutic strategies informed by positive results of randomised clinical trials. Commentary on Fox et al. The management of newly diagnosed large B-cell lymphoma A British Society for Haematology Guideline. Br J Haematol 2024; 2041178-1192.

Asunto(s)

Linfoma de Células B Grandes Difuso; Nivel de Atención; Humanos; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Ciclofosfamida/uso terapéutico; Doxorrubicina/uso terapéutico; Linfoma de Células B Grandes Difuso/tratamiento farmacológico; Linfoma de Células B Grandes Difuso/diagnóstico; Prednisona/uso terapéutico; Rituximab/uso terapéutico; Resultado del Tratamiento; Vincristina/uso terapéutico; Ensayos Clínicos Controlados Aleatorios como Asunto

Palabras clave

DLBCL; chemotherapy; immunotherapy; lymphomas

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Nivel de Atención Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google